SFDA- “Guideline on Requirements for Advertising and Promotion of Pharmaceutical and Herbal Products” V 7.0
The Saudi Food & Drug Authority (“SFDA”) has issued V 7.0 of
The Saudi Food & Drug Authority (“SFDA”) has issued V 7.0 of
NHRA issues updated “Medicine Renewal Guideline” (Version 2.1) & “Medicine Variations Guideline”
SFDA Issues Final CMC Guidance for Human Gene Therapy Clinical Trial Applications.
SFDA issues updated “Verification & Abridged Pathways” Guideline (Version 3.0 — Issued
The Saudi Food & Drug Authority (“SFDA”) has issued a new guidance
OMAN MOH issued new Circular No. 194/2025 – Mandatory Renewal of Pharmaceutical
Kuwait MoH issues “Guideline on the Preparation & Submission of eCTD Dossiers”
Qatar MOPH issues new Guideline on Braille Requirements for Labeling Information of
SFDA issues “Good Review Practices (GRevPs)” Guideline Version 1.0 🔍 What’s new:
SFDA publishes Version 4.0 of Data Requirements for Human Drug Submissions (August